Citation Impact
Citing Papers
Mutational landscape and significance across 12 major cancer types
2013 StandoutNature
CDK inhibitors: positive and negative regulators of G1-phase progression
1999 Standout
The p16INK4a/CDKN2A tumor suppressor and its relatives
1998
The RB and p53 pathways in cancer
2002 Standout
Ferroptosis as a p53-mediated activity during tumour suppression
2015 StandoutNature
The history of cancer epigenetics
2004 Standout
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein–methyltransferase superfamily
2001
Human papillomavirus oncoproteins: pathways to transformation
2010 Standout
DNA methylation in endometrial cancer
2010
Papillomavirus infections — a major cause of human cancers
1996 StandoutNobel
Immortalization and Transformation of Human Cells by Human Papillomavirus
1994
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Classification of papillomaviruses
2004 StandoutNobel
Trial Watch: Monoclonal antibodies in cancer therapy
2012
Loss of Net as Repressor Leads to Constitutive Increased c-fos Transcription in Cervical Cancer Cells
2004 StandoutNobel
Viruses in human cancers
1999 StandoutNobel
Cellular Senescence in Cancer and Aging
2007 Standout
Expression of Chr9p21 genes CDKN2B (p15), CDKN2A (p16, p14) and MTAP in human atherosclerotic plaque
2010
The molecular biology of head and neck cancer
2010 Standout
Mechanisms of bone invasion and metastasis in human neuroblastoma
2005
Human papillomavirus is a necessary cause of invasive cervical cancer worldwide
1999 Standout
ColonyArea: An ImageJ Plugin to Automatically Quantify Colony Formation in Clonogenic Assays
2014
Pancreatic Adenocarcinoma
2014 Standout
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Evidence for a Causal Association Between Human Papillomavirus and a Subset of Head and Neck Cancers
2000 Standout
Viruses in human cancers
1999 StandoutNobel
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
Cancer-epigenetics comes of age
1999 Standout
INK4a/ARF: A multifunctional tumor suppressor locus
2005
Molecular Pathogenesis of Cancer of the Cervix and Its Causation by Specific Human Papillomavirus Types
1994 StandoutNobel
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion
2005
Microenvironmental regulation of metastasis
2008 Standout
Neuroblastoma
2007 Standout
Disrupted dichotomous intracellular control of human papillomavirus infection in cancer of the cervix
1994 StandoutNobel
The molecular landscape of head and neck cancer
2018 Standout
Oncogenic DNA viruses
2001 StandoutNobel
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
2001
Cytokine Signaling in 2002
2002 Standout
Programmable design of orthogonal protein heterodimers
2018 StandoutNatureNobel
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
The Emerging Genetic Architecture of Type 2 Diabetes
2008
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition
2000 StandoutNobel
Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer
2003 Standout
Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-α mediated repression of viral transcription and modification of the AP-1 transcription complex
1999 StandoutNobel
Cellular senescence: from physiology to pathology
2014 Standout
STATs: transcriptional control and biological impact
2002 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
2003 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Retinoic acid inhibition of human papillomavirus type 16-mediated transformation of human keratinocytes.
1993
Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence
2003 Standout
Biology of Gastrointestinal Stromal Tumors
2004 Standout
ANRIL Expression Is Associated With Atherosclerosis Risk at Chromosome 9p21
2010
Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia.
1997
Human Papillomavirus and Cervical Cancer
2003 Standout
Disturbance of Tumor Necrosis Factor Alpha-Mediated Beta Interferon Signaling in Cervical Carcinoma Cells
2002 StandoutNobel
Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis
2004 StandoutNobel
Inhibition of growth, transformation, and expression of human papillomavirus type 16 E7 in human keratinocytes by alpha interferons
1993
ATP depletion + pyrimidine depletion can markedly enhance cancer therapy: fresh insight for a new approach.
2000
A Synthetic E7 Gene of Human Papillomavirus Type 16 That Yields Enhanced Expression of the Protein in Mammalian Cells and Is Useful for DNA Immunization Studies
2003 StandoutNobel
Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming
2011
High Prognostic Value of p16INK4 Alterations in Gastrointestinal Stromal Tumors
2003
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Cystine-Glutamate Transporter SLC7A11 in Cancer Chemosensitivity and Chemoresistance
2005
Works of A. Batova being referenced
Methylation of p16 in primary gynecologic malignancy
1999
Increased levels and constitutive tyrosine phosphorylation of the epidermal growth factor receptor contribute to autonomous growth of human papillomavirus type 16 immortalized human keratinocytes.
1994
Genomic cloning of methylthioadenosine phosphorylase: a purine metabolic enzyme deficient in multiple different cancers.
1996
The Ch14.18-GM-CSF fusion protein is effective at mediating antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in vitro.
1999
p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease.
2001
Promising results of a pilot trial of a GD2 directed anti-idiotypic antibody as a vaccine for high risk neuroblastoma
2004
Use of alanosine as a methylthioadenosine phosphorylase-selective therapy for T-cell acute lymphoblastic leukemia in vitro.
1999
Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoids.
1992
Frequent deletion in the methylthioadenosine phosphorylase gene in T- cell acute lymphoblastic leukemia: strategies for enzyme-targeted therapy
1996